Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq data.
Aurélie AG Gabriel, Julien Racle, Maryline Falquet, Camilla Jandus, David Gfeller
This paper develops EPIC-ATAC to estimate cancer and immune cell-type proportions from bulk tumor ATAC-Seq data, showing accurate prediction of immune contexture in breast cancer subtypes.
eLife · Oct 9, 2024Peer-reviewedBioinformatics